Arvinas Therapeutics, a biotech company specializing in PROTAC protein degradation technology, has a
market capitalization of around $20 billion as of its listing on Nasdaq in 2018. The company's market cap could potentially increase significantly in the future based on the progress of its clinical pipelines and the commercialization of its PROTAC-based therapies.
6
answers
KDramaLegendary
Fri Nov 08 2024
The current
market capitalization stands at a significant figure.
CryptoLodestarGuard
Thu Nov 07 2024
BTCC, a top cryptocurrency exchange, offers a range of services to its users.
Lucia
Thu Nov 07 2024
Specifically, it is valued at $1.80 Billion USD.
Paolo
Thu Nov 07 2024
This
market cap represents the total value of all the coins in circulation.
WhisperInfinity
Thu Nov 07 2024
It is a crucial metric used to gauge the health and popularity of a cryptocurrency.